Gb Sciences Inc (OP: GBLX )
0.0072
+0.0001
(+1.41%)
Streaming Delayed Price
Updated: 3:05 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Gb Sciences Inc
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.newswire.com/files/x/02/52/1bf44f6f1855a2a6cb98dbcb6007.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/18_41.png?width=1200&height=800&fit=crop)
![](/images/schema-image-default.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://cdn.newswire.com/files/x/a7/4b/3fc56c176e7cd96c721709055cba.jpg)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://cdn.benzinga.com/files/images/story/2022/11/01/cdc-98pi-jtfqp0-unsplash_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.newswire.com/files/x/98/b3/5b36c45e266c904fd888ec517b62.jpg)
Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients
November 01, 2022
Via Newswire.com
Topics
Cannabis
Exposures
Cannabis
![](https://cdn.newswire.com/files/x/01/b6/2129614f848034ef385fcfbe583e.jpg)
![](https://cdn.newswire.com/files/x/43/97/3deccb6620bf5e9d4617f522416f.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/10/clinical_trial_cannabisshutterstock4.jpg?width=1200&height=800&fit=crop)
![](https://cdn.newswire.com/files/x/43/83/5c7aa82d96cc03a86bb8f0ac3c5c.jpg)
Gb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's Disease
October 10, 2022
Via Newswire.com
Topics
Cannabis
Exposures
Cannabis
![](https://cdn.newswire.com/files/x/61/d2/9d1c43d3ad2a64439b6e951924f5.jpg)
TODAY: Gb Sciences Describes Drug Development Progress in Pharma's Almanac Journal Article
September 06, 2022
Via Newswire.com
Topics
Cannabis
Exposures
Cannabis
![](https://cdn.newswire.com/files/x/e5/da/8281fb2e453f06f7a6b36343fa5c.jpg)
Via Newswire.com
Topics
Intellectual Property
![](https://cdn.newswire.com/files/x/9c/9e/99f16ff167909d54b267fd831d95.jpg)
![](https://cdn.newswire.com/files/x/5f/44/5c3662b194dc7b50537134fabb50.jpg)
![](https://cdn.newswire.com/files/x/77/fb/eda906acb424a53b9b6d90f96c05.jpg)
Via Newswire.com
Exposures
COVID-19
![](https://cdn.benzinga.com/files/images/story/2022/04/12/17.png?width=1200&height=800&fit=crop)
![](https://cdn.newswire.com/files/x/82/34/a49dcd5fb7a3eadf43d65ecfb5f0.jpg)
![](https://cdn.newswire.com/files/x/fb/8a/a55cc9d6e1bfb733a91a820089f3.jpg)
Via Newswire.com
![](https://cdn.newswire.com/files/x/17/29/4e0481d69fcf4e8e5648b3f7607f.jpg)
![](https://cdn.newswire.com/files/x/17/29/4e0481d69fcf4e8e5648b3f7607f.jpg)
![](https://cdn.newswire.com/files/x/17/29/4e0481d69fcf4e8e5648b3f7607f.jpg)
![](https://cdn.newswire.com/files/x/39/d8/f1c68630d127e2817f153c9047df.jpg)
![](https://cdn.newswire.com/files/x/82/19/b470d8e9ed08e14838cfaffbb938.jpg)
Via Newswire.com
Topics
Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.